2016
DOI: 10.21147/j.issn.1000-9604.2016.05.10
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients

Abstract: Objective There is heterogeneity in the prognosis of gastric cancers staged according to the tumornodes- metastasis (TNM) system. This study evaluated the prognostic potential of an immune score system to supplement the TNM staging system. Methods An immunohistochemical analysis was conducted to assess the density of T cells, B cells, and myeloid-derived suppressor cells (MDSCs) in cancer tissues from 100 stage IIIA gastric cancer patients; the expression of the high-mobility group protein B1 (HMGB1) was also … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 36 publications
1
10
0
Order By: Relevance
“…Six studies reported the prognostic value of general TILs, [ 14 , 15 , 18 , 19 , 23 , 24 ] 9 studies about CD8 + T lymphocytes, [ 13 , 16 , 20 , 25 , 27 , 31 – 33 , 36 ] 14 studies about FOXP3 + T lymphocytes, [ 17 , 20 – 22 , 26 , 28 , 29 , 31 , 34 35 , 37 40 ] 2 about CD4 + T lymphocytes, [ 29 , 33 ] and 5 about CD3 + T lymphocytes. [ 12 , 20 , 28 , 30 , 32 ] Association between general TILs or its subsets and patients’ prognoses in each study was described in Table 3 .…”
Section: Resultsmentioning
confidence: 99%
“…Six studies reported the prognostic value of general TILs, [ 14 , 15 , 18 , 19 , 23 , 24 ] 9 studies about CD8 + T lymphocytes, [ 13 , 16 , 20 , 25 , 27 , 31 – 33 , 36 ] 14 studies about FOXP3 + T lymphocytes, [ 17 , 20 – 22 , 26 , 28 , 29 , 31 , 34 35 , 37 40 ] 2 about CD4 + T lymphocytes, [ 29 , 33 ] and 5 about CD3 + T lymphocytes. [ 12 , 20 , 28 , 30 , 32 ] Association between general TILs or its subsets and patients’ prognoses in each study was described in Table 3 .…”
Section: Resultsmentioning
confidence: 99%
“…Table II summarized the characteristics of all included studies [ 14 31 ]. The summarizes should represented by summarized incorporated studies were published from 2003 to 2016 and conducted in China ( n = 6), Germany ( n = 1), Korea ( n = 6), Japan ( n = 3), America ( n = 1), and Italy ( n = 1).…”
Section: Resultsmentioning
confidence: 99%
“…Lymphocyte-activation gene 3 (LAG3) is a transmembrane protein with structural homology to CD4 co-receptors [51]. It is found in activated CD4 T cells, regulatory T cells, Tr1 cells, activated CD8 T cells, natural killer cells, dendritic cells, B cells, and exhausted effector T cells [17,18]. LAG3 has multiple biological functions, for example, it is known to negatively regulate the proliferation, activation, and effector functions of T cells [52,53].…”
Section: Discussionmentioning
confidence: 99%
“…The ESTIMATE algorithm has been used in studies on multiple cancers, which have shown the effectiveness of such big databased algorithms [15,16]. Due to the prognostic signi cance of the integrated immune in ltration score in breast cancer [17], gastric cancer [18], oral squamous cell carcinoma [19], and ovarian cancer [20], its value can be used as an additional indicator to TNM staging system for patient survival prediction. However, very few studies have reported integrated immune in ltration in lung adenocarcinoma.…”
Section: Introductionmentioning
confidence: 99%